Reply to W. E. Rosa et al and T. N. Townsend et al
- 20 January 2022
- journal article
- letter
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 40 (3), 312-314
- https://doi.org/10.1200/jco.21.02383
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Opioid Prescribing to Patients With Advanced Cancer: Unanswered QuestionsJournal of Clinical Oncology, 2022
- The US Cancer Pain Crisis and the Global Pain Divide: Can Two Wrongs Make It Right?Journal of Clinical Oncology, 2022
- US Trends in Opioid Access Among Patients With Poor Prognosis Cancer Near the End-of-LifeJournal of Clinical Oncology, 2021
- Cancer pain self‐management in the context of a national opioid epidemic: Experiences of patients with advanced cancer using opioidsCancer, 2021
- Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage: the Lancet Commission reportThe Lancet, 2018
- Principles of Opioid Use in Cancer PainJournal of Clinical Oncology, 2014
- Access to opioid analgesics and pain relief for patients with cancerNature Reviews Clinical Oncology, 2013
- Prospective, Observational Study of Pain and Analgesic Prescribing in Medical Oncology Outpatients With Breast, Colorectal, Lung, or Prostate CancerJournal of Clinical Oncology, 2012
- Prevalence of undertreatment in cancer pain. A review of published literatureAnnals of Oncology, 2008
- Nonsteroidal Anti-Inflammatory Drugs, Alone or Combined With Opioids, for Cancer PainJournal of Clinical Oncology, 2004